SCHEMBL18929952

SCHEMBL18929952

CCC(C)(C)c1ccc(Cl)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.46
KMT2A Q03164 2/20 0.43
CYP19A1 P11511 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
TP53 P04637 1/20 0.40
NR3C1 P04150 5/20 0.40
NR3C2 P08235 3/20 0.40
LMNA P02545 3/20 0.40
MEN1 O00255 1/20 0.38
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
ALDH1A1 P00352 2/20 0.37
PGR P06401 1/20 0.37
KCNH2 Q12809 1/20 0.37
HPGD P15428 1/20 0.37
TTR P02766 1/20 0.36
HTT P42858 2/20 0.36
FLT1 P17948 1/20 0.36
FLT4 P35916 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL803017 0.81 TRPV4 (0.56) TRPV4KMT2ACYP19A1L3MBTL1TP53
SCHEMBL11449777 0.80 ACHE (0.50) KMT2AL3MBTL1MEN1ALDH1A1HPGD
SCHEMBL805037 0.80 CA12 (0.50) KMT2ALMNAMEN1ALDH1A1HPGD
SCHEMBL12894420 0.79 SMN1; SMN2 (0.38) KMT2ATP53LMNAMEN1ALDH1A1
SCHEMBL21230582 0.79 MAPT (0.50) KMT2ACYP19A1TP53LMNAMEN1
SCHEMBL2955499 0.78 CYP3A4 (0.47) KMT2ATP53NR3C1NR3C2LMNA
SCHEMBL16579380 0.78 TRPV4 (0.49) TRPV4KMT2ACYP19A1L3MBTL1TP53
SCHEMBL13763478 0.77 CYP3A4 (0.54) KMT2AL3MBTL1TP53LMNAMEN1
SCHEMBL27768786 0.77 NR3C1 (0.50) CYP19A1NR3C1NR3C2PGR
Hydrochloric Acid SCHEMBL31409980 0.76 TRPV4 (0.47) TRPV4KMT2ACYP19A1L3MBTL1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2922841-B1 ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES BRISTOL MYERS SQUIBB CO (US) 2017-06-07 EP disclosed